Patents
Sitemap › C07 - Organic chemistry › C07F - Acyclic, carbocyclic, or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium › C07F 9 - Compounds containing elements of the 5th group of the periodic system
Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
11/2003
11/27/2003WO2003053571A3 Catalyst comprising a complex of a metal of the viii. sub-group based on a ligand with an unbridged heterophosphacyclohexane structural element
11/27/2003WO2003053354A3 Fused cyclic modulators of nuclear hormone receptor function
11/27/2003US20030220523 Bis (aminostyryl) naphthalene compound, synthesis intermediate thereof, and process for production thereof
11/27/2003US20030220518 Forming at least two charged functional groups to provide for water-solubility and in vivo biodistribution; ionic mobility; metallization, carboxylation
11/27/2003US20030220323 Such as (2-(4-(2-(1-(3,5-Bis-trifluoromethyl-phenyl)-ethoxy)-1-phenyl-ethyl) -piperazin-1-yl)-ethoxy)-acetic acid; for prevention and/or treatment of conditions associated with pathogical levels of substance P
11/27/2003US20030220315 Such as 3',3"-dibromo-4',4"-dimethoxy-5',5"-bis-(methoxycarbonyl)-1,1 -diphenylethene; for treating viral diseases/retroviruses
11/27/2003US20030220304 Hydroxyphenstatin and the prodrugs thereof
11/27/2003US20030220303 GABAB Receptor Agonists; used to treat gastrointestinal disorders, especially GERD
11/27/2003US20030220298 Combrestatin a-1 phosphate and combrestatin b-1 phosphate prodrugs
11/27/2003US20030220297 Phosphorus-containing compounds and uses thereof
11/27/2003US20030219727 Prodrugs of phosphonate nucleotide analogues
11/27/2003CA2657002A1 Use of aromatic hydrocarbons and silicone fluids for making disphosphonic acids
11/27/2003CA2486151A1 Compound and processes for the preparation and use thereof
11/27/2003CA2486097A1 N-substituted tricyclic 3-aminopyrazoles as pdfg receptor inhibitors
11/27/2003CA2484234A1 Plating media
11/27/2003CA2456698A1 Polypeptide immobilization
11/26/2003EP1365463A2 Material for electrolytic solutions and use thereof
11/26/2003EP1364974A2 Substituted pyridyl amine ligands, complexes, catalysts and processes for polymerizing and polymers
11/26/2003EP1364956A1 Solvent systems for the production of bisphosphonates
11/26/2003EP1364955A1 Phosphorothionates
11/26/2003EP1364948A2 Biomimetic system of lipid membranes bonded to a substrate
11/26/2003EP1364212A2 Three hybrid assay system
11/26/2003EP1363922A2 Novel hydroxyaryl phosphine oxides, glycidyl ethers and epoxy compositions, composites and laminates derived therefrom
11/26/2003EP1363921A1 Halogenated phosphines
11/26/2003EP1363920A1 Modified psma ligands and uses related thereto
11/26/2003EP1363879A2 Sulfide and disulfide compounds and compositions for cholesterol management and related uses
11/26/2003EP1363502A2 Methods for treating organic acid-treated phosphatides
11/26/2003EP1257361B1 Phosphorous, arsenic and antimony compounds based on diaryl-anellated bicyclo[2.2.n] parent substances and catalysts containing same
11/26/2003EP1084131B1 Organophosphorus compounds for dental polymerizable compositions
11/26/2003EP0980289B1 Process for preparing carboxylic acid salts and catalysts useful in such process
11/26/2003EP0946572B1 Pharmaceutical aminophosphonic acid derivatives
11/26/2003CN1458158A Biphosphonate
11/26/2003CN1458157A New process for preparing N-phosphonomethyl iminodiacetic acid
11/26/2003CN1458144A Porous ligand unsatuated metal ligand compound
11/26/2003CN1128802C Phenyl-substituted cyclic ketoenol and pesticide and herbicide
11/26/2003CN1128790C 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents
11/25/2003USRE38334 Synthesis of D-3 phosphorylated phosphoinositides and analogues
11/25/2003USRE38333 Antiviral phosphonomethoxy nucleotide analogs having increased oral bioavailability
11/25/2003US6653508 Use treating various medical conditions, including pain
11/25/2003US6653495 Process for obtaining mixtures of phosphoric mono- and diesters
11/25/2003US6653494 Processes for producing triaryl phosphite
11/25/2003US6653485 Particularly effective in Ru-catalyzed asymmetric hydrogenation of beta-ketoesters to beta-hydroxyesters and ruthenium-catalyzed asymmetric hydrogenation of enamides to beta amino acids; catalyst selectivity
11/25/2003US6653473 Fluorescent quenching detection reagents and methods
11/25/2003US6653296 Antiretroviral enantiomeric nucleotide analogs
11/25/2003US6652834 Tensioactive properties, long lasting activity in the blood pool
11/25/2003CA2106370C Antibiotic compounds
11/20/2003WO2003095665A2 Pmea and pmpa cyclic producing synthesis
11/20/2003WO2003095470A1 Platinum complexes having antitumor activity
11/20/2003WO2003095464A1 Phosphatidyl oligo glycerins and structural analogs
11/20/2003WO2003095463A1 Neopentylglycol bis (diarylphosphate) esters
11/20/2003WO2003095414A1 Method of purifying quaternary alkylammonium salt and quaternary alkylammonium salt
11/20/2003WO2003095402A1 Method for producing c13-alcohol mixtures
11/20/2003WO2003094852A2 Hydroxyphosphonates and phosphonophosphates as apolipoprotein e modulators
11/20/2003WO2003094851A2 1,1- and 1,2-bisphosphonates as apoliprotein e modulators
11/20/2003WO2003094850A2 Lipid a and other carbohydrate ligand analogs
11/20/2003WO2003057173A3 Broad spectrum inhibitors
11/20/2003WO2003028629A3 Chlorin photosensitizing agents for use in photodynamic therapy
11/20/2003WO2003020809A3 Higher alkylated triaryl phosphate ester flame retardants
11/20/2003WO2003004157A3 Optically active catalysts containing a salen ligand and vanadium (iv), production thereof and use of the same for producing cyanohydrins
11/20/2003WO2002100860A3 Heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as anti-bacterial agents
11/20/2003US20030216599 Phase transfer agent; falme retarders for polyesters, polyurethane; solvent extraction
11/20/2003US20030216569 Viricides; Aids therapy
11/20/2003US20030216534 Modular cytomimetic biomaterials, transport studies, preparation and utilization thereof
11/20/2003US20030216533 Polymeric phosphinic acids and salts thereof
11/20/2003US20030216388 Cyclocarbamate derivatives as progesterone receptor modulators
11/20/2003US20030216356 Cause the selective destruction of tumour vasculature; are used to inhibit and/or reverse, and/or alleviate symptoms of angiogenesis
11/20/2003US20030215801 Method for immobilizing oligonucleotides employing the cycloaddition bioconjugation method
11/20/2003US20030213940 Such as ((4-methoxy)-4-(3-phosphoryloxyphenyl))spiro(1,2-dioxetane-3,13'-(8-n -propyl)tricyclo(7.3.1.02,7) tridec-2,7-ene), disodium salt; photosensitivity
11/20/2003CA2485431A1 Platinum complexes having antitumor activity
11/19/2003EP1362877A1 One-pack moisture-curing epoxy resin composition
11/19/2003EP1362876A1 One-pack moisture-curable epoxy resin composition
11/19/2003EP1362861A1 Macrocyclic chelants for metallopharmaceuticals
11/19/2003EP1362856A1 Water-soluble triazole fungicide
11/19/2003EP1362848A1 Process for the preparation of vitamin D derivatives
11/19/2003EP1362637A1 Porous coordinatively unsaturated metal complex
11/19/2003EP1362055A1 Coordination compounds and their use for the polymerization of olefins
11/19/2003EP1245551B1 1,2-bis(methyl(1,1,3,3-tetramethylbutyl)-phosphino)ethane, process for the preparation thereof, transition metal complexes containing the same as the ligand and uses thereof
11/19/2003EP1202998B1 Synthesis of stable quinone and photoreactive ketone phosphoramidite reagents for solid phase synthesis of photoreactive-oligomer conjugates
11/19/2003EP0901500B1 In situ preparation of nucleoside phosphoramidites and their use in synthesis of oligonucleotides
11/19/2003CN1456565A Bismuth color reagent of azofluorophosphine-DBF and its synthesis and use
11/18/2003US6649801 Anionic borate ligands and zwitterionic complexes formed therefrom
11/18/2003US6649622 Treating diabetes, especially Type II diabetes
11/18/2003US6649601 Bisphosphonic compound
11/18/2003US6649600 2,6-Dioxo or dithioxy-2,3,6,7-tetrahydro-1H-purin-8-yl)-bicyclo derivatives; highly potent and selective diuretics
11/18/2003US6649578 Di-carboxy alkyl phosphate esters in personal care applications
11/18/2003US6649558 Organometallic complexes having two unbridged phosphinimine ligands and at least one activatable ligand free of cyclopentadienyl, indenyl or fluorenyl ligand are catalyst components for olefin polymerization
11/18/2003CA2014518C Lipopolyamines, their preparation and their use
11/13/2003WO2003093282A1 Preparation of biphosphonic acids and salts thereof
11/13/2003WO2003093246A1 Ionic liquids
11/13/2003WO2003093228A1 Phthalamide derivative, agricultural or horticultural insecticide, and method of use thereof
11/13/2003WO2003093226A1 Process for synthesizing pharmaceutically active disulfide salts
11/13/2003WO2003092700A1 Inositol pyrophosphates, and methods of use thereof
11/13/2003WO2003092374A2 Pesticidal heterocycles
11/13/2003WO2003035008A3 Functionalized stilbene derivatives as improved vascular targeting agents
11/13/2003WO2003018192A3 Method for the production of 2-propylheptanol and hydroformylating catalysts and the further use thereof for carbonylation, hydrocyanation and hydrogenation
11/13/2003WO2002016327A8 Benzimidazoles and analogues and their use as neutrophil inhibitors
11/13/2003US20030212289 Reacting a diarylaminiobenzaldehyde with diphosphonate or diphosphonium compound
11/13/2003US20030212287 Epoxy-stabilized polyphosphate compositions
11/13/2003US20030212285 Methods for preparing ruthenium and osmium compounds and films
11/13/2003US20030212284 Stereoisomers or racemic mixture of complex
1 ... 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 ... 554